The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,364.00
Bid: 1,378.00
Ask: 1,382.00
Change: 18.00 (1.34%)
Spread: 4.00 (0.29%)
Open: 1,350.00
High: 1,396.00
Low: 1,348.00
Prev. Close: 1,346.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GHG digital application winning Gold Award

29 Jun 2021 13:30

RNS Number : 5164D
Georgia Capital PLC
29 June 2021
 

 London, 29 June 2021

 

 

 

GHG digital healthcare application winning Gold Award at EBRD Sustainability Awards 2021

Georgia Capital PLC announces that its 100% subsidiary, Georgia Healthcare Group ("GHG"), has today won the Gold Award in the Environmental & Social Innovation category at European Bank for Reconstruction and Development ("EBRD") Sustainability Awards 2021, for its new digital application - EKIMO.

 

EKIMO is an innovative, independent and fully integrated digital healthcare platform, that combines all components of primary healthcare: doctors, clinics, laboratories, radiology units, retail pharmacies and medical insurance. The application was launched in March 2020 and is open to any healthcare service provider or health product seller in the country. EKIMO is completely free for all users and provides quick and easy access to the entire healthcare ecosystem, such as: booking doctor appointments, online payments, online consultations, and pharmacy delivery.

 

Since its launch, EKIMO's network has expanded to 1,050 doctors from 60 different clinics, half of which are independent, third-party clinics. As of today, EKIMO is the largest digital healthcare platform in the country, from which more than 133,600 users are already benefiting.

 

 

 

 

Name of authorised official of issuer responsible for making notification: Giorgi Alpaidze, Chief Financial Officer

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 0.5 billion equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a healthcare services business; (ii) a water utility business; (iii) a retail (pharmacy) business, (iv) an insurance business (P&C and medical insurance); (v) a renewable energy business (hydro and wind assets) and (vi) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia and a 19.9% equity stake in LSE premium-listed Bank of Georgia Group PLC ("Bank of Georgia"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B'/FC & 'B'/LC

Moody's

B2/CFR & B2/PDR

 

About Georgia Healthcare Group

Georgia Healthcare Group is the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 17 hospitals and 34 clinics. GHG is the single largest market participant, accounting for 20% of the total hospital bed capacity in the country, as of 31 March 2021. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 32% market share by revenue and the largest provider of medical insurance in Georgia with a 25% market share based on net insurance premiums earned and approximately c.172,000 insurance customers. GHG employed a total of c.15,200 people as at 31 March 2021, including c.3,500 physicians and 2,900 pharmacists.

 

For further information, please visit www.georgiacapital.ge or contact: 

 

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

ir@gcap.ge

ir@gcap.ge

This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUKAURAKUNUAR
Date   Source Headline
24th Apr 202412:30 pmRNSNotice of Results
12th Apr 20247:00 amRNSNotice of AGM
8th Apr 202410:52 amRNSChange of Registered Office
3rd Apr 20245:29 pmRNSDirector/PDMR Shareholding
25th Mar 20245:29 pmRNSHolding(s) in Company
22nd Mar 20247:00 amRNSAnnual Financial Report
14th Mar 20245:13 pmRNSDirector/PDMR Shareholding
29th Feb 202410:13 amRNSCancellation of Treasury Shares
28th Feb 20247:00 amRNSDirector/PDMR Shareholding
23rd Feb 20243:58 pmEQSEdison issues update on Georgia Capital (CGEO): FY23 NAV TR of 20% in sterling terms
23rd Feb 20241:13 pmRNSTransaction in Own Shares
22nd Feb 20245:23 pmRNSTransaction in Own Shares
22nd Feb 20247:00 amRNSFinal Results
21st Feb 20245:58 pmRNSTransaction in Own Shares
20th Feb 20245:18 pmRNSTransaction in Own Shares
19th Feb 20242:19 pmRNSTransaction in Own Shares
16th Feb 20244:29 pmRNSTransaction in Own Shares
15th Feb 20244:24 pmRNSTransaction in Own Shares
15th Feb 20243:15 pmRNSNotice of Results
14th Feb 20245:05 pmRNSTransaction in Own Shares
13th Feb 20243:19 pmRNSTransaction in Own Shares
9th Feb 20245:12 pmRNSTransaction in Own Shares
8th Feb 20245:17 pmRNSTransaction in Own Shares
7th Feb 20244:45 pmRNSTransaction in Own Shares
6th Feb 20243:23 pmRNSTransaction in Own Shares
5th Feb 20244:48 pmRNSTransaction in Own Shares
2nd Feb 20241:40 pmRNSTransaction in Own Shares
1st Feb 20244:57 pmRNSTransaction in Own Shares
1st Feb 202411:49 amRNSTotal Voting Rights
31st Jan 20245:03 pmRNSCancellation of Treasury Shares
31st Jan 20244:48 pmRNSTransaction in Own Shares
30th Jan 20243:26 pmRNSTransaction in Own Shares
29th Jan 20242:28 pmRNSTransaction in Own Shares
26th Jan 20245:32 pmRNSTransaction in Own Shares
25th Jan 20244:27 pmRNSTransaction in Own Shares
24th Jan 20243:25 pmRNSTransaction in Own Shares
23rd Jan 20241:58 pmRNSHolding(s) in Company
23rd Jan 202412:09 pmRNSTransaction in Own Shares
22nd Jan 20245:26 pmRNSTransaction in Own Shares
19th Jan 20243:55 pmRNSTransaction in Own Shares
19th Jan 20242:45 pmRNSDirector/PDMR Shareholding
18th Jan 20244:00 pmRNSTransaction in Own Shares
17th Jan 20245:20 pmRNSTransaction in Own Shares
16th Jan 20244:19 pmRNSTransaction in Own Shares
15th Jan 20245:14 pmRNSTransaction in Own Shares
12th Jan 20243:05 pmRNSTransaction in Own Shares
11th Jan 20243:54 pmRNSTransaction in Own Shares
10th Jan 20244:19 pmRNSTransaction in Own Shares
9th Jan 20245:28 pmRNSTransaction in Own Shares
8th Jan 20245:02 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.